202 related articles for article (PubMed ID: 23834278)
1. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.
Tosso RD; Andujar SA; Gutierrez L; Angelina E; Rodríguez R; Nogueras M; Baldoni H; Suvire FD; Cobo J; Enriz RD
J Chem Inf Model; 2013 Aug; 53(8):2018-32. PubMed ID: 23834278
[TBL] [Abstract][Full Text] [Related]
2. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity.
Angelina E; Andujar S; Moreno L; Garibotto F; Párraga J; Peruchena N; Cabedo N; Villecco M; Cortes D; Enriz RD
Mol Inform; 2015 Jan; 34(1):28-43. PubMed ID: 27490860
[TBL] [Abstract][Full Text] [Related]
3. Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations.
Rojas S; Parravicini O; Vettorazzi M; Tosso R; Garro A; Gutiérrez L; Andújar S; Enriz R
Eur J Med Chem; 2020 Dec; 208():112792. PubMed ID: 32949964
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydroisoquinolines acting as dopaminergic ligands. A molecular modeling study using MD simulations and QM calculations.
Andujar S; Suvire F; Berenguer I; Cabedo N; Marín P; Moreno L; Dolores Ivorra M; Cortes D; Enriz RD
J Mol Model; 2012 Feb; 18(2):419-31. PubMed ID: 21523539
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies of Yersinia pestis dihydrofolate reductase.
Oliveira AA; Rennó MN; de Matos CA; Bertuzzi MD; Ramalho TC; Fraga CA; França TC
J Biomol Struct Dyn; 2011 Oct; 29(2):351-67. PubMed ID: 21875154
[TBL] [Abstract][Full Text] [Related]
6. Reaction-path energetics and kinetics of the hydride transfer reaction catalyzed by dihydrofolate reductase.
Garcia-Viloca M; Truhlar DG; Gao J
Biochemistry; 2003 Nov; 42(46):13558-75. PubMed ID: 14622003
[TBL] [Abstract][Full Text] [Related]
7. A DFT-based QSAR study on inhibition of human dihydrofolate reductase.
Karabulut S; Sizochenko N; Orhan A; Leszczynski J
J Mol Graph Model; 2016 Nov; 70():23-29. PubMed ID: 27649548
[TBL] [Abstract][Full Text] [Related]
8. Enzyme polarization of substrates of dihydrofolate reductase by different theoretical methods.
Greatbanks SP; Gready JE; Limaye AC; Rendell AP
Proteins; 1999 Nov; 37(2):157-65. PubMed ID: 10584062
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation.
de Souza FR; Guimarães AP; Cuya T; de Freitas MP; Gonçalves ADS; Forgione P; Costa França TC
J Biomol Struct Dyn; 2017 Oct; 35(13):2975-2986. PubMed ID: 27726597
[TBL] [Abstract][Full Text] [Related]
10. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
Singh P; Kaur M; Sachdeva S
J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
[TBL] [Abstract][Full Text] [Related]
11. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
[TBL] [Abstract][Full Text] [Related]
12. Effect of mutation on enzyme motion in dihydrofolate reductase.
Watney JB; Agarwal PK; Hammes-Schiffer S
J Am Chem Soc; 2003 Apr; 125(13):3745-50. PubMed ID: 12656604
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human dihydrofolate reductase activity and expression.
Abali EE; Skacel NE; Celikkaya H; Hsieh YC
Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
[TBL] [Abstract][Full Text] [Related]
14. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
15. Performance assessment of semiempirical molecular orbital methods in describing halogen bonding: quantum mechanical and quantum mechanical/molecular mechanical-molecular dynamics study.
Ibrahim MA
J Chem Inf Model; 2011 Oct; 51(10):2549-59. PubMed ID: 21942911
[TBL] [Abstract][Full Text] [Related]
16. Electron redistribution on binding of a substrate to an enzyme: folate and dihydrofolate reductase.
Bajorath J; Kitson DH; Fitzgerald G; Andzelm J; Kraut J; Hagler AT
Proteins; 1991; 9(3):217-24. PubMed ID: 2006139
[TBL] [Abstract][Full Text] [Related]
17. Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions.
Verkhivker GM; Rejto PA; Bouzida D; Arthurs S; Colson AB; Freer ST; Gehlhaar DK; Larson V; Luty BA; Marrone T; Rose PW
J Mol Recognit; 1999; 12(6):371-89. PubMed ID: 10611647
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening, docking, and dynamics of potential new inhibitors of dihydrofolate reductase from Yersinia pestis.
Bastos Lda C; de Souza FR; Guimarães AP; Sirouspour M; Cuya Guizado TR; Forgione P; Ramalho TC; França TC
J Biomol Struct Dyn; 2016 Oct; 34(10):2184-98. PubMed ID: 26494420
[TBL] [Abstract][Full Text] [Related]
19. Free energies of binding from large-scale first-principles quantum mechanical calculations: application to ligand hydration energies.
Fox SJ; Pittock C; Tautermann CS; Fox T; Christ C; Malcolm NO; Essex JW; Skylaris CK
J Phys Chem B; 2013 Aug; 117(32):9478-85. PubMed ID: 23841453
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
